Effects of High-Intensity Functional Training on Physical Fitness and Jumping Difficulty Movement

January 2, 2024 updated by: Wang Xinzhi, Universiti Putra Malaysia

Effects of High-Intensity Functional Training on Physical Fitness and Jumping Difficulty Movement Among University Male Wushu Routine Athletes in China

While prior research indicates the efficacy of High-Intensity Functional Training (HIFT) in improving physical fitness and skill performance across various sports , its effects on Wushu routine athletes still need to be determined. This study aims to explore the impact of high-intensity functional training on the physical fitness and jumping difficulty of Wushu routine athletes, providing valuable insights for coaches and athletes to optimize training plans. Coaches or sports researchers can use this knowledge to manage the training load of athletes better, thereby helping Wushu athletes achieve better results in Wushu jumping difficulty movements training.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Not yet recruiting

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

In this study, the intervention design part of the researchers referred to Greg Glassman's (2010) "CrossFit training guide" and designed a high-intensity functional training program based on the characteristics of wushu routines . This study employs a Cluster Randomized Controlled Trial (CRCT) design. The experimental period of this study is 12 weeks, three times per week. The training lasts 1.5 hours, including one hour of physical fitness training and half an hour of specialized technical training. The sample for this study is male Wushu routine athletes from the Hebei Institute of Physical Education and Hebei Normal University, with 60 participants. Athletes were randomly assigned to two different training locations and divided into experimental and control groups. The specialized skills training content of the two groups is the same, with the only difference being the physical training part. The experimental group received high-intensity functional training, while the control group maintained routine training. In addition, the specific content of routine training for the control group is the school's standard training plan. The dependent variables to be measured in this study are physical fitness (strength, power, speed, endurance, and flexibility) and jumping difficulty movements (Flying Kick, Whirl Wind Kick, Outward Leg Swing in Flight, and Side Somersaults). This study measured the dependent variable three times throughout the intervention: baseline before the experimental intervention, post-test 1 after 6 weeks, and post-test 2 after 12 weeks. Finally, statistical analysis was conducted on the three test results.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Estimated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
60

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Study Locations

  • Malaysia
    • Selangor
      • Serdang, Selangor, Malaysia, 43400
        • Kim Geok Soh

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Male.
  • Aged 18-23 years old.
  • Health.
  • No experience of high-intensity functional training.

Exclusion Criteria:

  • Athletes with physical surgery.
  • Have high-intensity functional training experience.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: Experimental group
The experimental group will undergo 60 minutes of high-intensity functional training.
Other: High Intensity Functional Training
12 weeks of high-intensity functional training, 3 times/week. Each class lasts 60 minutes, including warm-up, physical training, and cool down.
No Intervention: Control group
The control group will follow the curriculum standards set by the Sports University.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Effects of strength among college students
Time Frame: Baseline, post-test 1 after 6 weeks and post-test 2 after 12 weeks
Record the number of push-ups in 1 min.
Baseline, post-test 1 after 6 weeks and post-test 2 after 12 weeks
Effects of power among college students
Time Frame: Baseline, post-test 1 after 6 weeks and post-test 2 after 12 weeks
Measure the distance of the standing long jump with a measuring tape in centimeters (cm).
Baseline, post-test 1 after 6 weeks and post-test 2 after 12 weeks
Effects of endurance among college students
Time Frame: Baseline, post-test 1 after 6 weeks and post-test 2 after 12 weeks
Recorded the number of jumping ropes in 1 min.
Baseline, post-test 1 after 6 weeks and post-test 2 after 12 weeks
Effects of speed among college students
Time Frame: Baseline, post-test 1 after 6 weeks and post-test 2 after 12 weeks
Use a stopwatch to record the duration of the subject's 30 m sprint (in seconds).
Baseline, post-test 1 after 6 weeks and post-test 2 after 12 weeks
Effects of flexibility among college students
Time Frame: Baseline, post-test 1 after 6 weeks and post-test 2 after 12 weeks
Use the sit-and-reach box. The score is recorded as the point where their fingertips reach the measurement scale. The range of motion is measured in cm.
Baseline, post-test 1 after 6 weeks and post-test 2 after 12 weeks
Effects of Flying Kick among college students
Time Frame: Baseline, post-test 1 after 6 weeks and post-test 2 after 12 weeks
Record the flying kick using a high-speed camera and score it by experts.
Baseline, post-test 1 after 6 weeks and post-test 2 after 12 weeks
Effects of Whirlwind Kick among college students
Time Frame: Baseline, post-test 1 after 6 weeks and post-test 2 after 12 weeks
Record Whirl Wind Kick using a high-speed camera and score it by experts.
Baseline, post-test 1 after 6 weeks and post-test 2 after 12 weeks
Effects of Outward Leg Swing in Flight among college students
Time Frame: Baseline, post-test 1 after 6 weeks and post-test 2 after 12 weeks
Record outward leg swing in flight using a high-speed camera and score it by experts.
Baseline, post-test 1 after 6 weeks and post-test 2 after 12 weeks
Effects of Side Somersaults among college students
Time Frame: Baseline, post-test 1 after 6 weeks and post-test 2 after 12 weeks
Record side somersaults using a high-speed camera and have experts score them.
Baseline, post-test 1 after 6 weeks and post-test 2 after 12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Universiti Putra Malaysia

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Study Director: Kim Geok Soh, Professor

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

  • Bird, S., & Barrington-Higgs, B. (2010). Exploring the Deadlift. Strength & Conditioning Journal, 32(2), 46. https://doi.org/10.1519/SSC.0b013e3181d59582
  • Crossley, K. M., Zhang, W.-J., Schache, A. G., Bryant, A., & Cowan, S. M. (2011). Performance on the Single-Leg Squat Task Indicates Hip Abductor Muscle Function. The American Journal of Sports Medicine, 39(4), 866-873. https://doi.org/10.1177/0363546510395456
  • Feito, Y., Brown, C., & Olmos, A. (2019). A content analysis of the High-Intensity Functional Training Literature: A look at the past and directions for the future. Human Movement, 20(2), 1-15.
  • Glassman, G. (2010). The CrossFit training guide. CrossFit Journal, 30(1), 1-115
  • Ambroży, T., Rydzik, Ł., Kwiatkowski, A., Spieszny, M., Ambroży, D., Rejman, A., Koteja, A., Jaszczur-Nowicki, J., Duda, H., & Czarny, W. (2022). Effect of CrossFit Training on Physical Fitness of Kickboxers. International Journal of Environmental Research and Public Health, 19(8), 4526. https://doi.org/10.3390/ijerph19084526

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
January 1, 2024

Primary Completion (Estimated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
July 1, 2024

Study Completion (Estimated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
September 1, 2024

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
December 12, 2023

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
December 12, 2023

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
December 26, 2023

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
January 5, 2024

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
January 2, 2024

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
January 1, 2024

More Information

Terms related to this study

Keywords

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • Wang Xinzhi

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings